Corvidia Therapeutics
Waltham, US · Founded 2014 · 3 known investors
Founders & leadership
KH
KARIM HELMYNamed on SEC filing
MD
MARC DE GARIDELNamed on SEC filing
SG
SYLVIE GREGOIRENamed on SEC filing
TR
TYRELL RIVERSNamed on SEC filing
RA
RAM AIYARNamed on SEC filing
Board
AK
AARON KANTOFFBoard director
GS
GRAZIANO SEGHEZZIBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$60M disclosed across 1 round · 2018
▶$60MraisedMay 2018 · 15 investors · BiotechnologyRule 506(b)
▶$60MraisedMay 2018 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- AARON KANTOFFDirector
- KARIM HELMYDirector
- MARC DE GARIDELExecutive Officer, Director
- SYLVIE GREGOIREDirector
- TYRELL RIVERSDirector
- GRAZIANO SEGHEZZIDirector
- RAM AIYARExecutive Officer
- Offering amount
- $60M
- Amount sold
- $60M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Corvidia Therapeutics's investors?
- Corvidia Therapeutics's investors include Andera Partners, Scion Life Sciences, Sofinnova Partners.
- How much funding has Corvidia Therapeutics raised?
- Corvidia Therapeutics has disclosed $60M raised across 1 round.
- Where is Corvidia Therapeutics headquartered?
- Corvidia Therapeutics is headquartered in Waltham, US.